A Stem Cell Canard Returns!

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


In the National Review Kathryn Jean Lopez is touting, once again, adult-stem-cell research as the wave of the future, arguing that “embryonic-stem-cell is not the only hope for mankind,” and hence, there’s no need to pursue it. After all, adult stem cells are already being used for a variety of cures, whereas no one has ever been healed by embryonic stem cells. Well, okay, but nothing here logically rules out the future utility or even necessity of embryonic cells. Obviously the best thing to do from a scientific standpoint would be to pursue both—which, as it happens, is exactly what the International Society for Stem Cell Research has recommended.

Lopez then cites the pro-adult-stem-cell work of Michael Fumento, whose work on stem cell research was reviewed in Nature Biotech thusly:

The imprint of Fumento’s worldview is also evident in his chapter on stem cell research. It is clear that he finds embryonic stem cell research morally problematic. Yet, according to Fumento, the ethical dilemma over funding for embryo research could be rendered obsolete if focus were placed instead on adult stem cell research. Starting with the answer that adult stem cell research is good and embryonic stem cell research is bad, Fumento devotes his chapter on the topic to arguing that only adult stem cell research offers the potential for treatments and cures within the next few years, whereas much doubt clouds the possibility for success with embryonic research.

He also attempts to debunk the claim that adult stem cells are more limited in their plasticity than their embryonic counterparts, and argues that adult stem cells “may be superior in all ways.” Fumento insists that the embryonic stem cell research movement has been spearheaded by scientists with strong economic ties to the research, and that both journalists and politicians have been hoodwinked by the appeals of these scientists and their “disinformation” campaign.

Okay, so Fumento seems less a dispassionate scientist and more of an ideologue, but that doesn’t mean he’s wrong about everything. But it’s also a bit silly to ignore the strong scientific case for embryonic stem cell research: namely, that they are far more plastic than adult stem cells, can be used to generate any tissue in the body, and hence may one day be far more useful for curing degenerative diseases. Adult stem cells are almost certainly not “superior in all ways,” although a slew of right-wing researchers keep trumpeting shoddy results to try to prove otherwise. At any rate, the point here is that Lopez morally disapproves of embryonic-stem-cell research. Well, fine, but that’s no excuse for pretending to have scientific “evidence” to back up those vague moral feelings.

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate